These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7818937)

  • 1. Myocardial ischaemia: metabolic disorders leading to cell death.
    Bolli R
    Rev Port Cardiol; 1994 Sep; 13(9):649-53. PubMed ID: 7818937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants.
    Jeroudi MO; Hartley CJ; Bolli R
    Am J Cardiol; 1994 Mar; 73(6):2B-7B. PubMed ID: 8141076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-derived free radicals and myocardial reperfusion injury: an overview.
    Bolli R
    Cardiovasc Drugs Ther; 1991 Mar; 5 Suppl 2():249-68. PubMed ID: 1854667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.
    Moens AL; Claeys MJ; Timmermans JP; Vrints CJ
    Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion?
    Hearse DJ; Manning AS; Downey JM; Yellon DM
    Acta Physiol Scand Suppl; 1986; 548():65-78. PubMed ID: 3529823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The biochemical and cellular bases of myocardial ischemia-reperfusion damage].
    Téllez F; Carvajal K; García C; Vásquez C; Chávez E; Moreno-Sánchez R
    Arch Inst Cardiol Mex; 1996; 66(2):162-81. PubMed ID: 8768635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current research views on myocardial reperfusion and reperfusion injury.
    Yellon DM; Downey JM
    Cardioscience; 1990 Jun; 1(2):89-98. PubMed ID: 2102803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidative treatment in myocardial reperfusion ischemia].
    Artigou JY; Charniot JC; Bonnefont-Rousselot D; Salloum J; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():105-9. PubMed ID: 8304805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenomenon of paradox: myocardial reperfusion injury.
    Hudson KF
    Heart Lung; 1994; 23(5):384-93; quiz 394-6. PubMed ID: 7989207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention in ischaemia. Reperfusion syndrome. Rationale for trimetazidine.
    de Leiris J; Boucher F
    Rev Port Cardiol; 1994 Sep; 13(9):661-7. PubMed ID: 7818939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of free radical injury in myocardium.
    Reimer KA; Tanaka M; Murry CE; Richard VJ; Jennings RB
    Toxicol Pathol; 1990; 18(4 Pt 1):470-80. PubMed ID: 2091226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of ischemia--reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE).
    Ozer MK; Parlakpinar H; Acet A
    Clin Biochem; 2004 Aug; 37(8):702-5. PubMed ID: 15302615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trimetazidine and cardioprotection during ischemia-reperfusion].
    Barsotti A; Di Napoli P
    Ital Heart J; 2004 Mar; 5 Suppl 2():29S-36S. PubMed ID: 15074775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial stunning: an experimental act with a large clinical audience.
    Heyndrickx GR
    Arch Mal Coeur Vaiss; 2003 Jun; 96(6):665-70. PubMed ID: 12868349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs.
    Tanaka M; Richard VJ; Murry CE; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 1993 Apr; 25(4):367-78. PubMed ID: 8340930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of oxygen free radicals in ischemic reperfusion lesions to the myocardium].
    Kolowca J
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):299-302. PubMed ID: 8415239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.